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"Blind" interlaminar epidural steroid injections
in lumbar spinal stenosis; effective and safe technique
in elderly patients
Abstract
Background and purpose: Blind interlaminar epidural steroid injecti-
on (BESI) is one of the treatment modalities for lumbar spinal stenosis
(LSS). There are a growing number of elderly patients with LSS. The
optimal timing and outcome of BESIs in this population are not well
defined, which is the aim of this study.
Patients and methods: Thirty patients aged 67±1.5 yrs, with diagnosis
of LSS and refractory pain were recruited during year 2010 and followed up
for 12 months. “Blind” epidural in corresponding interspace was performed
with 18G Tuohy needle, using loss of resistance. The epidural mixture (10 ml)
consisted of 80 mg of triamcinolone acetonide and 40 mg of lidocaine. Each
patient received in total 3 BESIs every 3 weeks (BESI1, BESI2, BESI3).
The pain was evaluated with visual analogue scale (VAS) before first BESI
(VAS0) and after each treatment (VAS1, VAS2, VAS3). Subjective quality of
performing the same physical activity (PA) was evaluated with simple
3-points scale (0 = no change, 1 = slight improvement, 2 = significant
improvement).
Results: BESI resulted in significant reduction of VAS (VAS0 8.1±0.3,
VAS1 5.8±0.2, VAS2 4.9±0.2, VAS3 4.4±0.3; F=87.57, P< 0.001) – all
pair-wise comparisons were significantly different in post-hoc analysis
(P<0.001), except VAS2 vs VAS3 having borderline significance (P=0.06).
Subjective quality of physical activity significantly improved regarding
baseline conditions (BESI1 PA score: 0=1/30,1=7/30, 2=22/30 patients;
BESI2 PA score:0=1/30,1=5/30,2=24/30 patients; BESI 3 PA score:
0=4/30, 1=6/30, 2=20/30 patients; c2=3.7, p=0.45). The average dura-
tion of successful BESI treatment was 6.3±0.8 months (range 1–12). There
were no reported complications.
Conclusions: Blind interlaminar epidural steroid injections (in total 3
injections every 3 weeks) resulted in significant reduction of pain and
improvement of physical activity in elderly patients with LSS. It could be
regarded as effective and safe procedure in this population.
INTRODUCTION
Chronic low back pain (LBP) is a very common symptom reportedin all age groups (1). Mechanical LBP and herniated disc (HD)
syndromes are the most frequent causes in younger patients while the
lumbar spinal stenosis (LSS) primarily prevails in the middle-aged and
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age of 50–60 (1,2). Besides, the prevalence of LSS is
expected to increase significantly, together with increased
life expectancy (3).
LSS is defined as narrowing of the spinal canal with
encroachment on the neural structures by surrounding
bone and soft tissue (4). Typically, it presents with so-
called neurogenic claudication, which is described as
pain, weakness, paresthesia, or heaviness radiating to
lower extremities that occurs with walking or prolonged
standing (5).
Standard therapy for LBP includes pharmacotherapy
and various forms of physiotherapy maneuvers (6). In
refractory cases epidural steroid injections (ESI) are used
with intent to reduce inflammation. However, the ESI
have been administered mostly in patients with HD
syndrome, with good results (1). In LSS, there is some
controversy about using ESI. Not only there are 2 ap-
proaches for ESI (interlaminar and transforaminal) (7),
but there are also 2 ways for achieving proper epidural
position for steroid injection – fluoroscopically guided
and blind, depending only on the skills of the pain phy-
sician (8). Besides, there is a clinical dilemma about
overall success of interlaminar epidural steroid injections
in LSS (9,10).
The fluoroscopical guidance is not always available,
especially in minor hospitals, and the pain physician is
frequently forced to perform a blind epidural in a patient
with LSS complaining of severe LBP. The role, as well as
optimal timing, outcome and possible complications of
blind interlaminar ESI (BESI) in LSS have not been
well defined yet, which is the aim of this study.
PATIENT AND METHODS
Thirty patients aged 67±1.5 yrs, with diagnosis of
LSS and refractory pain were recruited during year 2010
and followed up for 12 months. The patients’ charac-
teristics are shown in Table 1. The inclusion criteria were
severe pain refractory to combined pharmacotherapy, as
well as severe pain or the presence of paresthesias after
5-minute standing and longer walking.
Before the procedure, every patient completed a con-
sent form. The day before procedure a patient was visited
and examined by an anesthesiologist, but received no
premedication. All ESI were done in the operating theatre
under strict sterile conditions. Firstly, intravenous can-
nula was inserted and infusion of 500 ml of Ringer
solution was administered. The ECG and NIBP were
monitored. Then “blind” epidural in corresponding lum-
bar interspace was performed by a trained anesthesi-
ologist (NE) using midline approach and 18-G Tuohy
disposable needle inserted in the sitting position. En-
trance into the epidural space was determined using the
loss of resistance method. Epidural mixture consisted of
triamcinolone acetonide 80 mg (Kenalog, Krka, Novo
Mesto, Slovenia) and lidocaine 40 mg (Lidokain 2%,
Belupo, Koprivnica, Croatia) diluted in normal saline to
a total volume of 10 ml, and injected into the epidural
space (L2–L3, L3–L4, L4–L5 or L5–S1 interspace).
After the procedure all patients were observed during 60
minutes, along with clinical evaluation and NIBP moni-
toring.
Each patient received in total 3 BESIs every 3 weeks
(BESI1, BESI2, BESI3). The pain was evaluated with
visual analogue scale (VAS) (11) before first BESI
(VAS0) and after each treatment (VAS1, VAS2, VAS3).
Subjective quality of performing the same physical acti-
vity (PA) regarding baseline conditions was evaluated
with simple 3-points scale (0 = no change, 1 = slight
improvement, 2=significant improvement).
The results were analyzed using Statistica 8.0 (Stat-
Soft, Inc., Tulsa, USA). VAS variable was analyzed with
one-way ANOVA followed by Bonferroni post hoc cor-
rection. One-way ANOVA and post hoc analyses were
used to provide information for all pair-wise compa-
risons of interest, both against baseline (VAS0), and be-
tween different VAS scores during the protocol. The
comparison of data on an ordinal scale (PA score) was
done using c2-test. Data were presented as mean±SEM.
P<0.05 was considered statistically significant.
RESULTS
Blind interlaminar epidural steroid injections result-
ed in significant reduction of pain as measured by visual
analogue scale (VAS0 8.1±0.3, VAS1 5.8±0.2, VAS2
236 Period biol, Vol 115, No 2, 2013.
N. Elezovi} et al. Blind interlaminar epidural steroids in lumbar spinal stenosis
TABLE 1
Charateristics of patients with lumbar spinal stenosis that
underwent 3 blind interlaminar epidural steroid injections
(n=30).
Age (yrs, mean±SEM, range) 67±1.5 (54–77)
Gender (M/F) 9/21
















* Takes into account only time from the first admission to Pain
Clinics till the first epidural steroid injection
† Many patients were administered several treatments (either
pharmacotherapy or physiotherapy) at the same time
4.9±0.2, VAS3 4.4±0.3; F=87.57, P< 0.001). All pair-
-wise comparisons were significantly different in post-hoc
analysis (P<0.001), except VAS2 versus VAS3 having
borderline significance (P=0.06) (Table 2).
Subjective quality of physical activity significantly im-
proved regarding baseline conditions, but the achieved
improved physical score did not change significantly
during the follow-up of all patients (Table 2).
The average duration of successful BESI treatment
was 6.3±0.8 months (range 1–12 months). There were
no reported complications, either while performing epi-
dural steroid injection or post procedurally.
DISCUSSION
In this study, three interlaminar epidural steroid injec-
tions, administered without fluoroscopic guidance every
three weeks, reduced significantly the pain as measured
by VAS and improved physical activity in this group of
older patients with LSS.
We consider LSS as an important health problem.
Recent advances in imaging technology, improvement in
diagnostic methods, and aging of the population have all
contributed that LSS is a very frequent diagnosis for pain
physician (12). Not only it is a disabling disease, which
significantly reduces quality of life, but it also represents
a huge economic burden on health system (13). Optimal
treatment regimen has not been determined yet (14), and
there is ongoing study trying to evaluate the effectiveness
of surgery compared with non-surgical interventions in
adults with symptomatic LSS (12). We hope that our
study might also help in determining optimal strategy for
the treatment of LSS.
The role of epidural injection therapy in chronic LBP
is still controversial and was evaluated in many studies.
In a systematic review about lumbar interlaminar epi-
dural injections in managing chronic LBP, out of the 3
evaluations studying the effectiveness of blind lumbar
interlaminar epidural injections in spinal stenosis, none
were shown to be positive for short-term or long-term
relief (15). Another systematic review found moderate
evidence for interlaminar epidurals in the cervical spine
and limited evidence in the lumbar spine for long-term
relief (16). However, the review from the Cochrane
Database covering 18 trials (1179 patients) stated that
injection therapy could be effective for particular sub-
group of patients, but there is still insufficient evidence to
support or refute the use of injection therapy (17). Ac-
cording to authors corticosteroids seem to be the most
logical therapeutic agent, while local anesthetics are only
useful for diagnostic purposes. In this study we have
chosen the combination of corticosteroid and local ane-
sthetic with obviously good results. We are also quite
satisfied with average duration of successful epidural
steroid therapy (6.3±0.8 months). Furthermore, we have
chosen the regimen of 3 epidural injections every 3 we-
eks. When analyzing results, one should note that VAS
after 3rd injection was not significantly less than VAS
after 2nd epidural injection (although we can speculate
about borderline significance). However, at the same
time, PA score did not improve significantly (Table 2),
and even after 3rd injection, 4 out of 30 patients did not
report any improvement. Nevertheless, since blind inter-
laminar epidural injection is an invasive procedure, and
taking into account aforementioned facts, our opinion is
that only 2 epidural steroid injections might be quite
adequate.
Much of the literature on lumbar interlaminar epi-
durals has been negative except in recent years when
fluoroscopic guidance was utilized (1). Fluoroscopically
guided caudal epidural steroid injections reduced bila-
teral radicular pain and improved standing and walking
tolerance in patients with LSS (18). However, we think
that in specific circumstances blind interlaminar tech-
nique should be strongly supported, as seen in this study.
In this group of 30 patients (i.e. 90 epidural injections)
we reported no complications, despite using “blind”
interlaminar approach. As stated before, the fluorosco-
pical guidance is not always available in our hospital.
Besides, we consider this technique much simpler and
the pain physician is not exposed to harmful X-ray radi-
ation. In addition, it is performed by anesthesiologist,
very experienced in performing not only epidural blocks,
but also in administering epidural anesthesia in every
day work.
In conclusion, blind interlaminar epidural steroid
injections (in total 3 injections every 3 weeks) resulted in
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TABLE 2
Visual analogue scale and physical activity scores before




PA score (n, %)††
0 1 2
BESI 0 VAS 0 = 8.1±0.3* N/A N/A N/A
BESI 1 VAS 1 = 5.8±0.2* 1 (3.3) 7 (23.3) 22 (73.3)
BESI 2 VAS 2 = 4.9±0.2*† 1 (3.3) 5 (16.7) 24 (80.0)
BESI 3 VAS 3 = 4.4±0.3*† 4 (13.3) 6 (20.0) 20 (66.7)
* One-way ANOVA (F=87.57, P<0.001); pair-wise compari-
sons were significantly different in post-hoc analysis, P<0.001
(VAS0 vs VAS1, VAS 0 vs VAS2, VAS0 vs VAS3, VAS 1 vs VAS2,
VAS1 vs VAS 3)




VAS = visual analogue scale; VAS 0 = VAS before the 1st blind
interlaminar epidural steroid injection (BESI 0); VAS 1 = VAS
after 1st blind interlaminar epidural steroid injection (BESI 1);
VAS 2 = VAS after 2nd blind interlaminar epidural steroid
injection (BESI 2); VAS 3 = VAS after 3rd blind interlaminar
epidural steroid injection (BESI 3);
PA score = physical activity scores after blind interlaminar epi-
dural injections in certain time points (BESI1, BESI2, BESI3); 0
= no improvement, 1 = slight improvement, 2 = significant
improvement; N/A = not applicable
significant reduction of pain and improvement of phy-
sical activity in elderly patients with LSS. It could be
regarded as effective and safe procedure in this popu-
lation.
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